EUVIMEDEUVIMED entdecken
LeserbriefKommentar

Linking the Who, What, When, and Where of Inpatient Direct Oral Penicillin Challenge With the How of Durable Penicillin Allergy Delabeling

Richard N Olans iD, Rita Drummond Olans iD

Clinical Infectious Diseases · 2024

DOI: 10.1093/cid/ciad478 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Clinical Infectious Diseases, 2024. Verfasst von Richard N Olans und 1 weiteren Autor:innen. Beteiligte Einrichtung: Tufts Medicine, Melrose-Wakefield Hospital, Melrose, Massachusetts, USA. Hauptthemen laut MEDLINE: Drug Hypersensitivity, Hypersensitivity. Die Arbeit nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug HypersensitivityHypersensitivityHumansPenicillinsInpatientsAnti-Bacterial AgentsSkin Tests

Substanzen

PenicillinsAnti-Bacterial Agents

Autor:innen und Institutionen

  • Tufts Medicine, Melrose-Wakefield Hospital, Melrose, Massachusetts, USA.
  • MGH Institute of Health Professions, Boston, Massachusetts, USA.

ORCID-Profile: Richard N Olans, Rita Drummond Olans

Zitieren

APA

Olans, R. N., & Olans, R. D. (2024). Linking the Who, What, When, and Where of Inpatient Direct Oral Penicillin Challenge With the How of Durable Penicillin Allergy Delabeling. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciad478

Vancouver

Olans RN, Olans RD. Linking the Who, What, When, and Where of Inpatient Direct Oral Penicillin Challenge With the How of Durable Penicillin Allergy Delabeling. Clinical Infectious Diseases. 2024. doi:10.1093/cid/ciad478

BibTeX
@article{Olans2024,
  author = {Olans, Richard N and Olans, Rita Drummond},
  title = {Linking the Who, What, When, and Where of Inpatient Direct Oral Penicillin Challenge With the How of Durable Penicillin Allergy Delabeling},
  journal = {Clinical Infectious Diseases},
  year = {2024},
  doi = {10.1093/cid/ciad478}
}
Kostenlos starten →